Time to Reconsider Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) After Less Short Sellers?

June 12, 2018 - By Ann Prendergast

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Logo

The stock of Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) registered a decrease of 10.75% in short interest. TNXP’s total short interest was 196,800 shares in June as published by FINRA. Its down 10.75% from 220,500 shares, reported previously. With 55,800 shares average volume, it will take short sellers 4 days to cover their TNXP’s short positions. The short interest to Tonix Pharmaceuticals Holding Corp’s float is 3.09%.

The stock increased 0.39% or $0.02 during the last trading session, reaching $4.3. About 62,700 shares traded. Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) has declined 28.97% since June 12, 2017 and is downtrending. It has underperformed by 41.54% the S&P500.

Tonix Pharmaceuticals Holding Corp. engages in developing pharmaceutical and biological products to address public health challenges. The company has market cap of $36.35 million. The Company’s lead product candidate, TNX-102 SL or Tonmya, designed as a bedtime treatment for posttraumatic stress disorder , which is in Phase 3 study in the military-related PTSD population. It currently has negative earnings. The firm is also developing TNX-601 (tianeptine oxalate), a clinical candidate at pre-IND (investigational new drug) application stage, designed as a daytime treatment for posttraumatic stress disorder (PTSD); and TNX-801, a live synthetic version of horsepox virus, at the pre-IND application stage.

More notable recent Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) news were published by: Nasdaq.com which released: “Tonix Pharmaceuticals to Present at the 2018 American Society of Clinical Psychopharmacology” on May 23, 2018, also Benzinga.com with their article: “28 Stocks Moving In Wednesday’s Mid-Day Session” published on June 06, 2018, Benzinga.com published: “40 Biggest Movers From Yesterday” on June 07, 2018. More interesting news about Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) were released by: Seekingalpha.com and their article: “Premarket analyst action – healthcare” published on June 06, 2018 as well as Nasdaq.com‘s news article titled: “Tonix Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Programs Update” with publication date: May 14, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: